| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016414A2 Composition for the elimination of autoreactive b-cells |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002016411A2 Binding polypeptides and methods based thereon |
| 02/28/2002 | WO2002016410A2 Peptide selection method |
| 02/28/2002 | WO2002016409A2 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 02/28/2002 | WO2002015977A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors |
| 02/28/2002 | WO2002015941A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 02/28/2002 | WO2002015932A1 Methods for treating demyelinating diseases |
| 02/28/2002 | WO2002015931A1 Immunologic method for the prevention of dental caries |
| 02/28/2002 | WO2002015930A1 Adjuvant |
| 02/28/2002 | WO2002015928A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015918A2 Method and compositions for promoting osteogenesis |
| 02/28/2002 | WO2002015906A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001083795A3 Particulate adenovirus, use thereof in vaccination |
| 02/28/2002 | WO2001083385A3 Devices and method for production of traceable immunizing drinking water, other liquids and gas |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001081361A8 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001078769A3 Regulation of systemic immune responses utilizing soluble cd40 |
| 02/28/2002 | WO2001078767A3 Pharmaceutical preparations comprising modified peptides |
| 02/28/2002 | WO2001075112A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/28/2002 | WO2001072281A3 Microspheres for active embolization |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001070774A3 Human t cell response to mhc-binding motif clusters |
| 02/28/2002 | WO2001070255A3 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 02/28/2002 | WO2001066691A3 Rickettsia felis outer membrane protein |
| 02/28/2002 | WO2001060849A3 Cold-adapted equine influenza viruses |
| 02/28/2002 | WO2001053339A3 Egg specific surface proteins |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001040266A3 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 02/28/2002 | WO2001036656B1 A complex between hyaluronic acid and a biomolecule and its use |
| 02/28/2002 | WO2001036614A3 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001030812A3 Activation of hcv-specific t cells |
| 02/28/2002 | WO2001027254A3 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | US20020026655 Genetically engineered Salmonella for use in the treatment of cancer |
| 02/28/2002 | US20020026041 Flea allantoinase nucleic acid molecules, proteins and uses thereof |
| 02/28/2002 | US20020026035 Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules |
| 02/28/2002 | US20020025981 Synergistic mixture of amlodipine and statins |
| 02/28/2002 | US20020025939 Chorionic gonadortropin dna vaccines and methods |
| 02/28/2002 | US20020025923 Antiinflammatory agents |
| 02/28/2002 | US20020025578 Intensified expression of nucleotide sequences in mammal; administer nucleic acids to mammal, transfect nucleotide sequence using voltage, monitor mammal for gene expression |
| 02/28/2002 | US20020025577 Eukaryotic gene expression cassette and uses thereof |
| 02/28/2002 | US20020025557 32447, a novel human acyltransferase and uses thereof |
| 02/28/2002 | US20020025543 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 02/28/2002 | US20020025330 Enhanced reconstitution feature and which avoids the settling out and aggregation |
| 02/28/2002 | US20020025329 For immunization |
| 02/28/2002 | US20020025328 As vaccines for immunization |
| 02/28/2002 | US20020025326 Delivery vehicle composition and methods for delivering antigens and other drugs |
| 02/28/2002 | US20020025325 Mixing a water soluble palatable flavorant with a water soluble vehicle for administration of an orally administered vaccine admixing with an antigen selected from bacterium and a virus as an active component; administering to animal |
| 02/28/2002 | US20020025324 For vaccinating a cow against mastitis |
| 02/28/2002 | US20020025323 Compositions and methods for enhancing immunogenicity of antigens |
| 02/28/2002 | US20020025322 Immunization of dairy cattle with Mig protein |
| 02/28/2002 | US20020025320 For use in boosting immune response; useful for enhancement of mucosal immune response |
| 02/28/2002 | US20020025318 Transferrin-binding proteins from n.gonorrhoeae and n. meningitidis |
| 02/28/2002 | US20020025317 For therapy and prophylaxis of pathological condition associated with expression of Interelukin-12 and/or Interleukin-18, including excessive or inappropriate amounts of those cytokines |
| 02/28/2002 | US20020025313 Targeting of liposomes to the blood-brain barrier |
| 02/28/2002 | CA2674888A1 Anti-ige vaccines |
| 02/28/2002 | CA2674838A1 Anti-ige vaccines |
| 02/28/2002 | CA2420543A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | CA2420526A1 Adjuvant |
| 02/28/2002 | CA2420499A1 Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide |
| 02/28/2002 | CA2420477A1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/28/2002 | CA2420260A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | CA2420235A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | CA2420234A1 Method of administering fimh protein as a vaccine for urinary tract infections |
| 02/28/2002 | CA2420193A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420176A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420140A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420101A1 Kidney-specific protein |
| 02/28/2002 | CA2420087A1 Cripto tumour polypeptide |
| 02/28/2002 | CA2420086A1 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 02/28/2002 | CA2419919A1 Novel imidazoline receptor homologs |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2419274A1 Methods and compositions for treating ige-related disease using nnt-1 inhibitors |
| 02/28/2002 | CA2418461A1 Method and compositions for promoting osteogenesis |
| 02/28/2002 | CA2388061A1 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | CA2356124A1 Anti-ige vaccines |
| 02/27/2002 | EP1182259A1 Pyruvate:NADP+ oxidoreductase and uses thereof |
| 02/27/2002 | EP1182210A1 Epitopes of tumor-associated MUC1 antigen |
| 02/27/2002 | EP1182208A2 Composition for DNA transfection |
| 02/27/2002 | EP1181937A2 Novel vaccine adjuvant and vaccine |
| 02/27/2002 | EP1181929A2 Method of potentiating an immune response and compositions therefor |
| 02/27/2002 | EP1181381A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 02/27/2002 | EP1181377A2 Protein conjugates, methods, vectors, proteins and dna for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 02/27/2002 | EP1181371A2 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 02/27/2002 | EP1181369A1 Four-helical bundle protein zsig81 |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181366A1 Mammalian receptor proteins; related reagents and methods |
| 02/27/2002 | EP1181320A2 Somatic transgene immunization and related methods |
| 02/27/2002 | EP1181319A1 Dr4 antibodies and uses thereof |